4/16
11:03 am
allo
Rating for ALLO
Low
Report
Rating for ALLO
4/16
08:00 am
allo
Allogene Therapeutics (ALLO) was upgraded by JPMorgan Chase & Co. from "underweight" to "neutral".
Medium
Report
Allogene Therapeutics (ALLO) was upgraded by JPMorgan Chase & Co. from "underweight" to "neutral".
4/16
05:22 am
allo
Allogene Therapeutics upgraded to Neutral from Underweight at JPMorgan
Medium
Report
Allogene Therapeutics upgraded to Neutral from Underweight at JPMorgan
4/15
02:37 pm
allo
Rating for ALLO
Medium
Report
Rating for ALLO
4/15
02:37 pm
allo
Rating for ALLO
Medium
Report
Rating for ALLO
4/14
11:41 am
allo
Rating for ALLO
High
Report
Rating for ALLO
4/14
11:41 am
allo
Rating for ALLO
High
Report
Rating for ALLO
4/14
11:34 am
allo
Rating for ALLO
High
Report
Rating for ALLO
4/14
08:57 am
allo
Allogene Therapeutics (ALLO) had its "market perform" rating reaffirmed by Sanford C. Bernstein.
High
Report
Allogene Therapeutics (ALLO) had its "market perform" rating reaffirmed by Sanford C. Bernstein.
4/14
07:46 am
allo
Rating for ALLO
High
Report
Rating for ALLO
4/14
07:46 am
allo
Rating for ALLO
High
Report
Rating for ALLO
4/14
07:13 am
allo
Allogene Therapeutics (ALLO) had its "buy" rating reaffirmed by HC Wainwright.
High
Report
Allogene Therapeutics (ALLO) had its "buy" rating reaffirmed by HC Wainwright.
4/14
07:13 am
allo
Allogene Therapeutics (ALLO) had its "outperform" rating reaffirmed by Citigroup Inc..
High
Report
Allogene Therapeutics (ALLO) had its "outperform" rating reaffirmed by Citigroup Inc..
3/13
02:06 pm
allo
Rating for ALLO
Low
Report
Rating for ALLO